Results: 4

2.
Figure 3.

Figure 3. From: Improved Neuropsychological and Neurological Functioning Across Three Antiretroviral Regimens in Diverse Resource-Limited Settings: AIDS Clinical Trials Group Study A5199, the International Neurological Study.

Median (Q1, Q3) changes in grooved pegboard from baseline. *Test scores improved at each follow-up visit compared to baseline (each P value < .01 by Wilcoxon signed-rank test). Abbreviations: Dom, dominant; Non-Dom, non-dominant.

K. Robertson, et al. Clin Infect Dis. 2012 September 15;55(6):868-876.
3.
Figure 4.

Figure 4. From: Improved Neuropsychological and Neurological Functioning Across Three Antiretroviral Regimens in Diverse Resource-Limited Settings: AIDS Clinical Trials Group Study A5199, the International Neurological Study.

Country differences in grooved pegboard dominant hand. *P-values for each comparison with India: Brazil (P = .01), Malawi (P = .49), Peru (P < .01), South Africa (P = .83), Thailand (P < .01), and Zimbabwe (P = .27). India was chosen as the reference country due to having the largest sample size. Abbreviations: CI, confidence interval; Dom, dominant.

K. Robertson, et al. Clin Infect Dis. 2012 September 15;55(6):868-876.
4.
Figure 2.

Figure 2. From: Improved Neuropsychological and Neurological Functioning Across Three Antiretroviral Regimens in Diverse Resource-Limited Settings: AIDS Clinical Trials Group Study A5199, the International Neurological Study.

Improvements in neurological disease, human immunodeficiency virus RNA, and CD4 cell counts over time. *Test scores improved at each follow-up visit compared to baseline (each P value < .01 by Wilcoxon signed-rank test). Abbreviations: CNS, central nervous system; HIV, human immunodeficiency virus.

K. Robertson, et al. Clin Infect Dis. 2012 September 15;55(6):868-876.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk